Altimmune, Inc. Insider Trading for December 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Altimmune, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Altimmune, Inc. for December 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 27 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.77 | 27,706 | 49,040 | 492,043 | 464.3 K to 492 K (+5.97 %) |
Dec 27 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.76 | 50,000 | 88,170 | 464,337 | 414.3 K to 464.3 K (+12.07 %) |
Dec 27 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.81 | 51,442 | 93,269 | 414,337 | 362.9 K to 414.3 K (+14.18 %) |
Dec 27 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.61 | 17,982 | 28,877 | 362,895 | 344.9 K to 362.9 K (+5.21 %) |
Dec 15 2017 | PIP | Altimmune, Inc. | Truffle Capital S.A.S. | 10% Owner | Option Exercise | J | 2.67 | 23 | 61 | 159 | |
Dec 15 2017 | PIP | Altimmune, Inc. | Truffle Capital S.A.S. | 10% Owner | Option Exercise | J | 2.67 | 30 | 80 | 212 | |
Dec 15 2017 | PIP | Altimmune, Inc. | Truffle Capital S.A.S. | 10% Owner | Option Exercise | J | 2.67 | 23 | 61 | 159 | |
Dec 15 2017 | PIP | Altimmune, Inc. | Truffle Capital S.A.S. | 10% Owner | Buy | J | 0.00 | 4,337 | 0 | 42,773 | 38.4 K to 42.8 K (+11.28 %) |
Dec 15 2017 | PIP | Altimmune, Inc. | Truffle Capital S.A.S. | 10% Owner | Buy | J | 0.00 | 5,784 | 0 | 93,947 | 88.2 K to 93.9 K (+6.56 %) |
Dec 15 2017 | PIP | Altimmune, Inc. | Truffle Capital S.A.S. | 10% Owner | Buy | J | 0.00 | 4,337 | 0 | 145,500 | 141.2 K to 145.5 K (+3.07 %) |
Dec 15 2017 | PIP | Altimmune, Inc. | Truffle Capital S.A.S. | 10% Owner | Buy | J | 0.00 | 16,018 | 0 | 38,436 | 22.4 K to 38.4 K (+71.45 %) |
Dec 15 2017 | PIP | Altimmune, Inc. | Truffle Capital S.A.S. | 10% Owner | Buy | J | 0.00 | 21,357 | 0 | 88,163 | 66.8 K to 88.2 K (+31.97 %) |
Dec 15 2017 | PIP | Altimmune, Inc. | Truffle Capital S.A.S. | 10% Owner | Buy | J | 0.00 | 16,018 | 0 | 141,163 | 125.1 K to 141.2 K (+12.80 %) |
Dec 15 2017 | PIP | Altimmune, Inc. | Novartis Bioventures Ltd | 10% Owner | Option Exercise | J | 2.67 | 345 | 921 | 2,415 | |
Dec 15 2017 | PIP | Altimmune, Inc. | Novartis Bioventures Ltd | 10% Owner | Buy | J | 0.00 | 65,718 | 0 | 2,357,975 | 2.3 M to 2.4 M (+2.87 %) |
Dec 15 2017 | PIP | Altimmune, Inc. | Novartis Bioventures Ltd | 10% Owner | Buy | J | 0.00 | 242,694 | 0 | 2,292,257 | 2 M to 2.3 M (+11.84 %) |
Dec 08 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.74 | 7,639 | 13,308 | 344,913 | 337.3 K to 344.9 K (+2.26 %) |
Dec 08 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.80 | 16,106 | 28,996 | 337,274 | 321.2 K to 337.3 K (+5.01 %) |
Dec 05 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.78 | 13,495 | 23,987 | 321,168 | 307.7 K to 321.2 K (+4.39 %) |
Dec 05 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.81 | 7,300 | 13,195 | 307,673 | 300.4 K to 307.7 K (+2.43 %) |
Dec 05 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.80 | 5,215 | 9,405 | 300,373 | 295.2 K to 300.4 K (+1.77 %) |